STONEPINE CAPITAL, L.P. purchased 0.2% of their position (6.24K shares) of NOVELION THERAPEUTICS INC. on the open market
Open‑market purchase worth $4.3K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/12/2019ACC: 0001567619-19-022982
10% Owner
Since Sep 2019
+6.24K
Net shares
Net buyer
$4.3K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
6.24K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.20K
Price / share
$0.69
Trade value
$3.60K
% of position
0.1%
12/10/2019
3.90M→3.91M
Common Stock
Direct
Shares
+40.00
Price / share
$0.69
Trade value
$27.60
% of position
0.0%
12/11/2019
3.91M→3.91M
Common Stock
Direct
Shares
+1K
Price / share
$0.70
Trade value
$700.00
% of position
0.0%
12/12/2019
3.91M→3.91M
Total
Net shares
+6.24K
Net value
$4.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2019 | P · Purchase | +5.20K | $0.69 | $3.60K | 0.1% | 3.90M | 3.91M |
| Common Stock Direct | 12/11/2019 | P · Purchase | +40.00 | $0.69 | $27.60 | 0.0% | 3.91M | 3.91M |
| Common Stock Direct | 12/12/2019 | P · Purchase | +1K | $0.70 | $700.00 | 0.0% | 3.91M | 3.91M |
| Total | +6.24K | $4.33K | ||||||
Derivative Transactions0
No derivative transactions reported